News & Views
Partnership Improves Scalable Culture Solutions
Oct 19 2018
Under a collaborative agreement, Sartorius Stedim Biotech (SSB) is to integrate Repligen’s ATF cell retention control technology into its large-scale single-use bioreactors providing a single control system for 50 L to 2,000 L bioreactors used in perfusion cell culture applications. SSB’s recently launched single-use mini bioreactor system will also be equipped with Repligen’s hollow fiber filter technology.
“Sartorius Stedim Biotech has continuously expanded its integrated upstream portfolio over the past years with a focus on robust and scalable, automated single-use solutions, optimised for high-cell-density applications. The collaboration with Repligen will result in easy-to-implement, high-performance and perfusion-ready bioreactors ranging from process development to commercial manufacturing scale,” commented Stefan Schlack, Head of Marketing at SSB.
Christine Gebski, Vice President of Product Management at Repligen, stated, “We are excited to partner with Sartorius Stedim Biotech, a global innovator in bioreactor technology. The integration of our market-leading XCell™ ATF control technology with SSB’s high-performance bioreactors offers a simplified perfusion-enabled bioreactor solution for end users to develop cell culture processes more quickly and implement perfusion more efficiently.”
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE